{"filing":{"accession":"0001231919-26-001107","url":"/filing/0001231919-26-001107","form_type":"4","issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_name_source":null,"issuer_ticker":"TRDA","issuer_url":"/issuer/0001689375","period_of_report":"2026-08-24","filed_date":"2026-08-26","acceptance_dt":"2026-08-26T21:28:15+00:00","acceptance_label":"2026-08-26 21:28 UTC","ingested_at":"2026-08-27T05:24:39.644631+00:00","ingested_label":"2026-08-27 05:24 UTC","schema_version":null,"source":"Layline","parse_status":"parsed","parse_ok":true,"edgar_url":"https://www.sec.gov/Archives/edgar/data/1689375/0001231919-26-001107-index.htm","day_url":"/filings/2026-08-26"},"owners":[{"owner_cik":"0001134655","owner_name":"GADICKE ANSBERT","url":"/insider/0001134655","anchor":"owner-0001134655","role":"Ten percent owner","officer_title":null,"is_director":false,"is_officer":false,"is_ten_percent":true,"is_other":false,"filing_anchor":"/filing/0001231919-26-001107#owner-0001134655"},{"owner_cik":"0001134657","owner_name":"EVNIN LUKE","url":"/insider/0001134657","anchor":"owner-0001134657","role":"Ten percent owner","officer_title":null,"is_director":false,"is_officer":false,"is_ten_percent":true,"is_other":false,"filing_anchor":"/filing/0001231919-26-001107#owner-0001134657"},{"owner_cik":"0001473930","owner_name":"Foley Todd","url":"/insider/0001473930","anchor":"owner-0001473930","role":"Ten percent owner","officer_title":null,"is_director":false,"is_officer":false,"is_ten_percent":true,"is_other":false,"filing_anchor":"/filing/0001231919-26-001107#owner-0001473930"},{"owner_cik":"0001609492","owner_name":"MPM BioVentures 2014, L.P.","url":"/insider/0001609492","anchor":"owner-0001609492","role":"Ten percent owner","officer_title":null,"is_director":false,"is_officer":false,"is_ten_percent":true,"is_other":false,"filing_anchor":"/filing/0001231919-26-001107#owner-0001609492"},{"owner_cik":"0001609493","owner_name":"MPM BioVentures 2014 (B), L.P.","url":"/insider/0001609493","anchor":"owner-0001609493","role":"Ten percent owner","officer_title":null,"is_director":false,"is_officer":false,"is_ten_percent":true,"is_other":false,"filing_anchor":"/filing/0001231919-26-001107#owner-0001609493"},{"owner_cik":"0001609495","owner_name":"MPM Asset Management Investors BV2014 LLC","url":"/insider/0001609495","anchor":"owner-0001609495","role":"Ten percent owner","officer_title":null,"is_director":false,"is_officer":false,"is_ten_percent":true,"is_other":false,"filing_anchor":"/filing/0001231919-26-001107#owner-0001609495"},{"owner_cik":"0001729504","owner_name":"MPM BIOVENTURES 2018 (B), L.P.","url":"/insider/0001729504","anchor":"owner-0001729504","role":"Ten percent owner","officer_title":null,"is_director":false,"is_officer":false,"is_ten_percent":true,"is_other":false,"filing_anchor":"/filing/0001231919-26-001107#owner-0001729504"},{"owner_cik":"0001734817","owner_name":"MPM ASSET MANAGEMENT INVESTORS BV2018 LLC","url":"/insider/0001734817","anchor":"owner-0001734817","role":"Ten percent owner","officer_title":null,"is_director":false,"is_officer":false,"is_ten_percent":true,"is_other":false,"filing_anchor":"/filing/0001231919-26-001107#owner-0001734817"},{"owner_cik":"0001765021","owner_name":"MPM BioVentures 2014 LLC","url":"/insider/0001765021","anchor":"owner-0001765021","role":"Ten percent owner","officer_title":null,"is_director":false,"is_officer":false,"is_ten_percent":true,"is_other":false,"filing_anchor":"/filing/0001231919-26-001107#owner-0001765021"},{"owner_cik":"0001765091","owner_name":"MPM BioVentures 2014 GP LLC","url":"/insider/0001765091","anchor":"owner-0001765091","role":"Ten percent owner","officer_title":null,"is_director":false,"is_officer":false,"is_ten_percent":true,"is_other":false,"filing_anchor":"/filing/0001231919-26-001107#owner-0001765091"}],"line_owners":[{"owner_name":"EVNIN LUKE; Foley Todd; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014 LLC; MPM BioVentures 2014, L.P.","role":"Ten percent owner"}],"transactions":[{"id":9302136,"accession":"0001231919-26-001107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-001107","line_url":"/filing/0001231919-26-001107#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":null,"owner_name":"EVNIN LUKE; Foley Todd; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014 LLC; MPM BioVentures 2014, L.P.","owner_display_name":"EVNIN LUKE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21623.0,"shares_display":"21,623","price_per_share":7.34,"price_display":"7.34","price_state":"stated","total_value":158712.82,"total_display":"158,712.82","total_whole":"158,713","shares_owned_after":4359439.0,"shares_owned_after_display":"4,359,439","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-24","filed_date":"2026-08-26","scope":"global","indirect_nature":"See Footnote","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9302135,"accession":"0001231919-26-001107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-26-001107","line_url":"/filing/0001231919-26-001107#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":null,"owner_name":"EVNIN LUKE; Foley Todd; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014 LLC; MPM BioVentures 2014, L.P.","owner_display_name":"EVNIN LUKE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26522.0,"shares_display":"26,522","price_per_share":7.54,"price_display":"7.54","price_state":"stated","total_value":199975.88,"total_display":"199,975.88","total_whole":"199,976","shares_owned_after":4332917.0,"shares_owned_after_display":"4,332,917","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-25","filed_date":"2026-08-26","scope":"global","indirect_nature":"See Footnote","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9302134,"accession":"0001231919-26-001107","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001231919-26-001107","line_url":"/filing/0001231919-26-001107#line-3","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":null,"owner_name":"EVNIN LUKE; Foley Todd; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014 LLC; MPM BioVentures 2014, L.P.","owner_display_name":"EVNIN LUKE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14569.0,"shares_display":"14,569","price_per_share":7.06,"price_display":"7.06","price_state":"stated","total_value":102857.14,"total_display":"102,857.14","total_whole":"102,857","shares_owned_after":4318348.0,"shares_owned_after_display":"4,318,348","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-26","filed_date":"2026-08-26","scope":"global","indirect_nature":"See Footnote","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null}],"n_transactions":3,"line_constants":{"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true},"provenance":{"source_pass":"Layline","parse_status":"parsed","schema_version":null,"retrieved_at":"2026-08-27T05:24:39.644631+00:00","retrieved_label":"2026-08-27 05:24 UTC","primary_document":"https://www.sec.gov/Archives/edgar/data/1689375/0001231919-26-001107-index.htm","accepted_at":"2026-08-26T21:28:15+00:00","accepted_label":"2026-08-26 21:28 UTC"},"related":[{"accession":"0001231919-26-001106","url":"/filing/0001231919-26-001106","form_type":"4","issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_name_source":null,"issuer_ticker":"TRDA","issuer_url":"/issuer/0001689375","period_of_report":"2026-08-24","filed_date":"2026-08-26","acceptance_dt":"2026-08-26T21:27:36+00:00","acceptance_label":"2026-08-26 21:27 UTC","ingested_at":"2026-08-27T05:24:39.644631+00:00","ingested_label":"2026-08-27 05:24 UTC","schema_version":null,"source":"Layline","parse_status":"parsed","parse_ok":true,"edgar_url":"https://www.sec.gov/Archives/edgar/data/1689375/0001231919-26-001106-index.htm","day_url":"/filings/2026-08-26"}],"related_rule":"Other filings held for the same issuer and the same period of report. This is a heuristic match, not an authoritative amendment link: the store holds no 4/A-to-original relation and the catalog does not invent one.","canonical_url":"https://ebomi.com/filing/0001231919-26-001107","retrieved_at":"2026-08-27T20:48:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}